Selected research
Industry Research
Bioconjugates Service Industry Research Report 2026
Market perspective
The global Bioconjugates Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioconjugates Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioconjugates Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioconjugates Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioconjugates Service include CellMosaic, AAT Bioquest, Creative Biolabs, Lonza, Bio-Synthesis, NJ Bio, Macrocyclics, KareBay and MuseChem, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioconjugates Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioconjugates Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioconjugates Service Market by Company
CellMosaic
AAT Bioquest
Creative Biolabs
Lonza
Bio-Synthesis
NJ Bio
Macrocyclics
KareBay
MuseChem
CheMatech
Recipharm
Nanocs
Vector Laboratories
Cell Signaling Technology
Thermo Fisher
WuXi Biologics
Celares
GTP Bioways
Antibody Solutions
BOC Sciences
Novasep
Bioconjugates Service Segment by Type
Covalent Conjugation Service
Non-Covalent Conjugation Service
Site-specific Conjugation Service
Bioconjugates Service Segment by Application
Therapeutic Drug Development
Diagnostic Probe Manufacturing
Basic Biological Research
Other
Bioconjugates Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioconjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugates Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioconjugates Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Covalent Conjugation Service
- Non-Covalent Conjugation Service
- Site-specific Conjugation Service
Applications
- Therapeutic Drug Development
- Diagnostic Probe Manufacturing
- Basic Biological Research
- Other
Companies covered
- CellMosaic
- AAT Bioquest
- Creative Biolabs
- Lonza
- Bio-Synthesis
- NJ Bio
- Macrocyclics
- KareBay
- MuseChem
- CheMatech
- Recipharm
- Nanocs
- Vector Laboratories
- Cell Signaling Technology
- Thermo Fisher
- WuXi Biologics
- Celares
- GTP Bioways
- Antibody Solutions
- BOC Sciences
- Novasep
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioconjugates Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Covalent Conjugation Service
- 2.2.3 Non-Covalent Conjugation Service
- 2.2.4 Site-specific Conjugation Service
- 2.3 Bioconjugates Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Therapeutic Drug Development
- 2.3.3 Diagnostic Probe Manufacturing
- 2.3.4 Basic Biological Research
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Bioconjugates Service Breakdown Data by Type
- 3.1 Global Bioconjugates Service Historic Market Size by Type (2021-2026)
- 3.2 Global Bioconjugates Service Forecasted Market Size by Type (2027-2032)
4 Bioconjugates Service Breakdown Data by Application
- 4.1 Global Bioconjugates Service Historic Market Size by Application (2021-2026)
- 4.2 Global Bioconjugates Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioconjugates Service Market Perspective (2021-2032)
- 5.2 Global Bioconjugates Service Growth Trends by Region
- 5.2.1 Global Bioconjugates Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioconjugates Service Historic Market Size by Region (2021-2026)
- 5.2.3 Bioconjugates Service Forecasted Market Size by Region (2027-2032)
- 5.3 Bioconjugates Service Market Dynamics
- 5.3.1 Bioconjugates Service Industry Trends
- 5.3.2 Bioconjugates Service Market Drivers
- 5.3.3 Bioconjugates Service Market Challenges
- 5.3.4 Bioconjugates Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioconjugates Service Players by Revenue
- 6.1.1 Global Top Bioconjugates Service Players by Revenue (2021-2026)
- 6.1.2 Global Bioconjugates Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioconjugates Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioconjugates Service Head Office and Area Served
- 6.4 Global Bioconjugates Service Players, Product Type & Application
- 6.5 Global Bioconjugates Service Manufacturers Established Date
- 6.6 Global Bioconjugates Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioconjugates Service Market Size (2021-2032)
- 7.2 North America Bioconjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioconjugates Service Market Size by Country (2021-2026)
- 7.4 North America Bioconjugates Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioconjugates Service Market Size (2021-2032)
- 8.2 Europe Bioconjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioconjugates Service Market Size by Country (2021-2026)
- 8.4 Europe Bioconjugates Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioconjugates Service Market Size (2021-2032)
- 9.2 Asia-Pacific Bioconjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioconjugates Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioconjugates Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioconjugates Service Market Size (2021-2032)
- 10.2 South America Bioconjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioconjugates Service Market Size by Country (2021-2026)
- 10.4 South America Bioconjugates Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioconjugates Service Market Size (2021-2032)
- 11.2 Middle East & Africa Bioconjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioconjugates Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioconjugates Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CellMosaic
- 12.1.1 CellMosaic Company Information
- 12.1.2 CellMosaic Business Overview
- 12.1.3 CellMosaic Revenue in Bioconjugates Service Business (2021-2026)
- 12.1.4 CellMosaic Bioconjugates Service Product Portfolio
- 12.1.5 CellMosaic Recent Developments
- 12.2 AAT Bioquest
- 12.2.1 AAT Bioquest Company Information
- 12.2.2 AAT Bioquest Business Overview
- 12.2.3 AAT Bioquest Revenue in Bioconjugates Service Business (2021-2026)
- 12.2.4 AAT Bioquest Bioconjugates Service Product Portfolio
- 12.2.5 AAT Bioquest Recent Developments
- 12.3 Creative Biolabs
- 12.3.1 Creative Biolabs Company Information
- 12.3.2 Creative Biolabs Business Overview
- 12.3.3 Creative Biolabs Revenue in Bioconjugates Service Business (2021-2026)
- 12.3.4 Creative Biolabs Bioconjugates Service Product Portfolio
- 12.3.5 Creative Biolabs Recent Developments
- 12.4 Lonza
- 12.4.1 Lonza Company Information
- 12.4.2 Lonza Business Overview
- 12.4.3 Lonza Revenue in Bioconjugates Service Business (2021-2026)
- 12.4.4 Lonza Bioconjugates Service Product Portfolio
- 12.4.5 Lonza Recent Developments
- 12.5 Bio-Synthesis
- 12.5.1 Bio-Synthesis Company Information
- 12.5.2 Bio-Synthesis Business Overview
- 12.5.3 Bio-Synthesis Revenue in Bioconjugates Service Business (2021-2026)
- 12.5.4 Bio-Synthesis Bioconjugates Service Product Portfolio
- 12.5.5 Bio-Synthesis Recent Developments
- 12.6 NJ Bio
- 12.6.1 NJ Bio Company Information
- 12.6.2 NJ Bio Business Overview
- 12.6.3 NJ Bio Revenue in Bioconjugates Service Business (2021-2026)
- 12.6.4 NJ Bio Bioconjugates Service Product Portfolio
- 12.6.5 NJ Bio Recent Developments
- 12.7 Macrocyclics
- 12.7.1 Macrocyclics Company Information
- 12.7.2 Macrocyclics Business Overview
- 12.7.3 Macrocyclics Revenue in Bioconjugates Service Business (2021-2026)
- 12.7.4 Macrocyclics Bioconjugates Service Product Portfolio
- 12.7.5 Macrocyclics Recent Developments
- 12.8 KareBay
- 12.8.1 KareBay Company Information
- 12.8.2 KareBay Business Overview
- 12.8.3 KareBay Revenue in Bioconjugates Service Business (2021-2026)
- 12.8.4 KareBay Bioconjugates Service Product Portfolio
- 12.8.5 KareBay Recent Developments
- 12.9 MuseChem
- 12.9.1 MuseChem Company Information
- 12.9.2 MuseChem Business Overview
- 12.9.3 MuseChem Revenue in Bioconjugates Service Business (2021-2026)
- 12.9.4 MuseChem Bioconjugates Service Product Portfolio
- 12.9.5 MuseChem Recent Developments
- 12.10 CheMatech
- 12.10.1 CheMatech Company Information
- 12.10.2 CheMatech Business Overview
- 12.10.3 CheMatech Revenue in Bioconjugates Service Business (2021-2026)
- 12.10.4 CheMatech Bioconjugates Service Product Portfolio
- 12.10.5 CheMatech Recent Developments
- 12.11 Recipharm
- 12.11.1 Recipharm Company Information
- 12.11.2 Recipharm Business Overview
- 12.11.3 Recipharm Revenue in Bioconjugates Service Business (2021-2026)
- 12.11.4 Recipharm Bioconjugates Service Product Portfolio
- 12.11.5 Recipharm Recent Developments
- 12.12 Nanocs
- 12.12.1 Nanocs Company Information
- 12.12.2 Nanocs Business Overview
- 12.12.3 Nanocs Revenue in Bioconjugates Service Business (2021-2026)
- 12.12.4 Nanocs Bioconjugates Service Product Portfolio
- 12.12.5 Nanocs Recent Developments
- 12.13 Vector Laboratories
- 12.13.1 Vector Laboratories Company Information
- 12.13.2 Vector Laboratories Business Overview
- 12.13.3 Vector Laboratories Revenue in Bioconjugates Service Business (2021-2026)
- 12.13.4 Vector Laboratories Bioconjugates Service Product Portfolio
- 12.13.5 Vector Laboratories Recent Developments
- 12.14 Cell Signaling Technology
- 12.14.1 Cell Signaling Technology Company Information
- 12.14.2 Cell Signaling Technology Business Overview
- 12.14.3 Cell Signaling Technology Revenue in Bioconjugates Service Business (2021-2026)
- 12.14.4 Cell Signaling Technology Bioconjugates Service Product Portfolio
- 12.14.5 Cell Signaling Technology Recent Developments
- 12.15 Thermo Fisher
- 12.15.1 Thermo Fisher Company Information
- 12.15.2 Thermo Fisher Business Overview
- 12.15.3 Thermo Fisher Revenue in Bioconjugates Service Business (2021-2026)
- 12.15.4 Thermo Fisher Bioconjugates Service Product Portfolio
- 12.15.5 Thermo Fisher Recent Developments
- 12.16 WuXi Biologics
- 12.16.1 WuXi Biologics Company Information
- 12.16.2 WuXi Biologics Business Overview
- 12.16.3 WuXi Biologics Revenue in Bioconjugates Service Business (2021-2026)
- 12.16.4 WuXi Biologics Bioconjugates Service Product Portfolio
- 12.16.5 WuXi Biologics Recent Developments
- 12.17 Celares
- 12.17.1 Celares Company Information
- 12.17.2 Celares Business Overview
- 12.17.3 Celares Revenue in Bioconjugates Service Business (2021-2026)
- 12.17.4 Celares Bioconjugates Service Product Portfolio
- 12.17.5 Celares Recent Developments
- 12.18 GTP Bioways
- 12.18.1 GTP Bioways Company Information
- 12.18.2 GTP Bioways Business Overview
- 12.18.3 GTP Bioways Revenue in Bioconjugates Service Business (2021-2026)
- 12.18.4 GTP Bioways Bioconjugates Service Product Portfolio
- 12.18.5 GTP Bioways Recent Developments
- 12.19 Antibody Solutions
- 12.19.1 Antibody Solutions Company Information
- 12.19.2 Antibody Solutions Business Overview
- 12.19.3 Antibody Solutions Revenue in Bioconjugates Service Business (2021-2026)
- 12.19.4 Antibody Solutions Bioconjugates Service Product Portfolio
- 12.19.5 Antibody Solutions Recent Developments
- 12.20 BOC Sciences
- 12.20.1 BOC Sciences Company Information
- 12.20.2 BOC Sciences Business Overview
- 12.20.3 BOC Sciences Revenue in Bioconjugates Service Business (2021-2026)
- 12.20.4 BOC Sciences Bioconjugates Service Product Portfolio
- 12.20.5 BOC Sciences Recent Developments
- 12.21 Novasep
- 12.21.1 Novasep Company Information
- 12.21.2 Novasep Business Overview
- 12.21.3 Novasep Revenue in Bioconjugates Service Business (2021-2026)
- 12.21.4 Novasep Bioconjugates Service Product Portfolio
- 12.21.5 Novasep Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst